BioClinica profit slides in 3Q

BioClinica ($BIOC), a provider of clinical trials software and imaging core lab services, saw its profits fall in the third quarter. The company's GAAP net income fell from $808,000 in the third quarter of last year to $358,000 in the recent third quarter. Yet its quarterly revenue was up from $18.3 million to $21.5 million, RTTNews reported. Article

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.